Literature DB >> 8739432

Power spectrum analysis contribution to the detection of cardiovascular dysautonomia in multiple sclerosis.

M Frontoni1, M Fiorini, S Strano, S Cerutti, F Giubilei, C Urani, S Bastianello, C Pozzilli.   

Abstract

In multiple sclerosis (MS) autonomic cardiovascular dysfunction is an uncommon, but potentially dangerous event, to which studies of spectral analysis of heart rate variability have not been applied, yet. MATERIAL AND METHODS--We studied 16 patients with definite MS (11 women and 5 men, mean age 30.3 +/- 7.4 yrs., mean EDSS 2.06 +/- 1.42) and 16 sex- and age-matched healthy controls. Besides cardiovascular reflex tests (valsalva manoeuvre, deep breathing, lying to standing, Blood Pressure response to standing and sustained handgrip), each underwent spectral analysis of the R-R interval short-term variability at rest and after tilting, to detect three components: very low frequency (VLF), low frequency (LF) and high frequency (HF). A recent brain MRI was obtained from patients, to compare plaque characteristics with spectral parameters. RESULTS--At cardiovascular reflexes, only four patients (25%) showed an impairment, mostly of a mild degree. VLF and LF at rest were lower in MS subjects than in controls (p < 0.01). No significant correlation was found between spectral parameters and lesion area or localization as detected on MRI. CONCLUSIONS--Spectral analysis could usefully flank reflex tests to detect autonomic subclinical cardiovascular abnormalities.

Entities:  

Mesh:

Year:  1996        PMID: 8739432     DOI: 10.1111/j.1600-0404.1996.tb00514.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  14 in total

1.  Is fatigue in patients with multiple sclerosis related to autonomic dysfunction?

Authors:  L Keselbrener; S Akselrod; A Ahiron; M Eldar; Y Barak; Z Rotstein
Journal:  Clin Auton Res       Date:  2000-08       Impact factor: 4.435

2.  P wave duration and dispersion in multiple sclerosis.

Authors:  Abdulkadir Kocer; Osman Karakaya; Ramazan Kargin; Irfan Barutcu; Ali Metin Esen
Journal:  Clin Auton Res       Date:  2005-12       Impact factor: 4.435

Review 3.  Autonomic dysfunction in multiple sclerosis: implications for exercise.

Authors:  Mu Huang; Ollie Jay; Scott L Davis
Journal:  Auton Neurosci       Date:  2014-10-23       Impact factor: 3.145

Review 4.  Painful and involuntary multiple sclerosis.

Authors:  Francesca Bagnato; Diego Centonze; Simonetta Galgani; Maria Grazia Grasso; Shalom Haggiag; Stefano Strano
Journal:  Expert Opin Pharmacother       Date:  2011-02-17       Impact factor: 3.889

5.  Abnormal heart rate and blood pressure responses to baroreflex stimulation in multiple sclerosis patients.

Authors:  Emmanuel O Sanya; Marcin Tutaj; Clive M Brown; Nursel Goel; Bernhard Neundörfer; Max J Hilz
Journal:  Clin Auton Res       Date:  2005-06       Impact factor: 4.435

Review 6.  Heart rate variability and fatigue in MS: two parallel pathways representing disseminated inflammatory processes?

Authors:  Guadalupe Garis; Michael Haupts; Thomas Duning; Helmut Hildebrandt
Journal:  Neurol Sci       Date:  2022-09-20       Impact factor: 3.830

7.  Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.

Authors:  Khalil Kanjwal; Beverly Karabin; Yousuf Kanjwal; Blair P Grubb
Journal:  Int J Med Sci       Date:  2010-03-11       Impact factor: 3.738

8.  Reduced spontaneous sympathetic nerve activity in multiple sclerosis patients.

Authors:  David M Keller; Paul J Fadel; Melissa A Harnsberger; Gina M Remington; Elliot M Frohman; Scott L Davis
Journal:  J Neurol Sci       Date:  2014-07-01       Impact factor: 3.181

Review 9.  [Therapy of day time fatigue in patients with multiple sclerosis].

Authors:  Udo A Zifko
Journal:  Wien Med Wochenschr       Date:  2003

10.  Impaired carotid baroreflex control of arterial blood pressure in multiple sclerosis.

Authors:  Mu Huang; Dustin R Allen; David M Keller; Paul J Fadel; Elliot M Frohman; Scott L Davis
Journal:  J Neurophysiol       Date:  2016-04-13       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.